National Cancer Institute   U.S. National Institutes of Healthwww.cancer.gov
 
Home   |   Data & Statistics   |   Collaborations   |   Work with Us   |   Publications   |   About   |   Links

Performance Measures for 273,601 Diagnostic Mammography Examinations1 from 1996 to 2007 by Age

PPV22 Abnormal Interpretation3
Total 37.7% 8.8%
Age 40-44 22.5% 8.8%
Age 45-49 29.3% 8.7%
Age 50-54 33.7% 8.4%
Age 55-59 41.1% 8.1%
Age 60-64 42.6% 8.0%
Age 65-69 46.8% 8.5%
Age 70-74 51.4% 9.2%
Age 75-89 56.3% 11.4%

1 Diagnostic mammography examination: Mammography examinations indicated by the radiologist to be for evaluation of a breast problem.

2 PPV2 (Positive Predictive Value 2) = The percentage of examinations with a positive interpretation& that result in a tissue diagnosis of cancer§.

3 Abnormal interpretation = The percentage of examinations with a positive interpretation&.

§ Cancers = Examinations with a tissue diagnosis of ductal carcinoma in situ or invasive cancer within 30 days prior to or 1 year following the examination. Non-cancers = Examinations without a tissue diagnosis of ductal carcinoma in situ or invasive cancer within 30 days prior to or 1 year following the examination.

& Positive interpretation = BI-RADS category 0 or 3 with a recommendation for biopsy, 4, or 5. Negative interpretation = BI-RADS category 1, 2, 0 with no recommendation for biopsy nor additional imaging/work-up, or 3 with no recommendation for biopsy.

[Return to Diagnostic Performance]


National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal Maintained by the Applied Research Program,
Division of Cancer Control and Population Sciences